A Level Playing Field? Medicare Tries To Balance Transparency, Confidentiality With Drug Price Negotiations

shredded paper
Medicare wants drug companies to keep confidential and later destroy materials related to a drug subject to government negotiations. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access